DRGs下临床药师利用信息化临床路径参与合理用药管理:以静脉用甘草酸制剂为例

目的 以静脉用甘草酸制剂为例，探讨DRGs背景下临床药师利用信息化临床路径参与合理用药管理。方法 利用PDCA循环理论，建立评价方案，发现我院静脉用甘草酸制剂使用问题，根据诊疗需要判断静脉用甘草酸制剂在路径中的必要性并进行剔除与维护。比较干预前后同期（2021年二季度vs.2022年二季度）用药合理率及监测指标变化。结果 与2021年同期比较，2022年二季度静脉用甘草酸制剂使用合理率有一定提高，使用率、日人均静脉给药次数、使用强度、例均药费均降低。结论 DRGs背景下临床药师利用信息化临床路径参与合理用药管理可以减少静脉用甘草酸制剂的不合理使用，降低医院监控指标。

Clinical Pharmacists Participate in Rational Drug Use Management by Informatization Clinical Pathway under DRGs: A Case Study of Intravenous Glycyrrhizic Acid Preparation

OBJECTIVE Taking intravenous glycyrrhizic acid preparation as an example, to discuss the participation of clinical pharmacists in rational drug use management by informatization clinical pathway under DRGs background. METHODS Based on the PDCA cycle theory, the evaluation scheme was established to find the problems in the use of intravenous glycyrrhizic acid preparation in our hospital, and the necessity of intravenous glycyrrhizic acid preparation in the pathway was determined according to the needs of diagnosis and treatment, and the elimination and maintenance were carried out. The rational rate of drug use and the changes of monitoring indexes were compared before and after intervention in the same period (Q2 2021 vs. Q2 2022). RESULTS Compared with the same period in 2021, the rational use rate of intravenous glycyrrhizic acid preparation increased to a certain extent in the second quarter of 2022, and the utilization rate, the number of intravenous administration per capita per day, the intensity of use and the average drug cost per case all decreased. CONCLUSION Under the background of DRGs, the participation of clinical pharmacists in rational drug use by informatization clinical pathway can reduce the irrational use of intravenous glycyrrhizic acid preparations and reduce the hospital monitoring index.